Multi-endpoint in vitro toxicological assessment of snus and tobacco-free nicotine pouch extracts

Modern oral tobacco-free nicotine pouches (NPs) are products containing nicotine, designed to resemble traditional snus in appearance and concept. They are marketed as alternatives to tobacco products, raising questions about their safety and health effects.

This assessment uses a three-step in vitro approach, including ToxTracker, to analyze biological responses such as oxidative stress, cell stress, protein damage, and DNA damage caused by these products. The findings aim to inform public health strategies and regulatory decisions.

Understanding the biological effects of nicotine pouches is essential for evaluating their safety compared to traditional tobacco products. This information can guide public health policies and consumer choices.

As these products become more popular, assessing their potential to cause cellular damage is crucial for preventing health risks associated with nicotine consumption.

This research provides valuable insights into the safety profile of tobacco-free nicotine products, informing public health initiatives aimed at reducing nicotine-related harm.

It helps policymakers develop regulations to ensure consumer safety and promote healthier alternatives.

The findings support the need for regulatory oversight of nicotine pouches, including safety testing and labeling requirements. They also highlight the importance of monitoring new nicotine delivery products in the market.

Effective policies can help minimize health risks and protect vulnerable populations from potential harms.